JHP Pharmaceuticals has entered into a manufacturing agreement with an undisclosed pharmaceutical company that has developed proprietary products that provide sustained and localized drug concentration. The agreement is for technical transfer, registration batch manufacture and commercial supply of a unique, late-stage ophthalmic product. JHP’s manufacturing expertise and cGMP compliance history were critical factors in the selection process. Stuart Hinchen, JHP’s president and chief exec...